The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 7, Pages 1021
Publisher
MDPI AG
Online
2019-07-22
DOI
10.3390/cancers11071021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Profiling of Invasive Breast Carcinoma Circulating Tumour Cells—Are We Ready for the ‘Liquid’ Revolution?
- (2019) Marcin Braun et al. Cancers
- Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer: A retrospective consecutive study
- (2019) Salvatore Pece et al. EBioMedicine
- Clinical Trials of Thermosensitive Nanomaterials: An Overview
- (2019) Stefania Nardecchia et al. Nanomaterials
- TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis
- (2019) Alec N. Woosley et al. ONCOGENE
- First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors
- (2019) Ignacio Garrido-Laguna et al. INTERNATIONAL JOURNAL OF CANCER
- A Review of the Role of Wnt in Cancer Immunomodulation
- (2019) Whitney N. Goldsberry et al. Cancers
- Phase I study of immunotherapy for advanced ROR1+ malignancies with autologous ROR1-specific chimeric antigen receptor-modified (CAR)-T cells.
- (2018) Jennifer M Specht et al. JOURNAL OF CLINICAL ONCOLOGY
- Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review
- (2018) Jiang Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The viable circulating tumor cells with cancer stem cells feature, where is the way out?
- (2018) Y. T. Luo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer
- (2018) Hatem Soliman et al. Oncotarget
- Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer
- (2018) Chun-Wen Cheng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma
- (2018) Iris Rabinovich et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma
- (2018) Long Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
- (2018) Sònia Palomeras et al. MOLECULES
- Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth
- (2018) Maria Giovanna Scioli et al. PLoS One
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progress in nonviral gene therapy for breast cancer and what comes next?
- (2017) Giulia Bottai et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Molecular genetics and targeted therapy of WNT-related human diseases (Review)
- (2017) Masuko Katoh et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
- (2017) Fakhar ud Din et al. International Journal of Nanomedicine
- Mesenchymal stem cells: key players in cancer progression
- (2017) Sarah M. Ridge et al. Molecular Cancer
- Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer
- (2017) Jeffrey C. Liu et al. PLoS One
- Molecular characterization of breast cancer CTCs associated with brain metastasis
- (2017) Debasish Boral et al. Nature Communications
- A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study
- (2017) Alberto Ocana et al. Oncotarget
- Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance
- (2017) Jae Moon Gwak et al. Oncotarget
- Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration
- (2017) Ibrahim Y. Hachim et al. Scientific Reports
- Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
- (2017) Julia Tchou et al. Cancer Immunology Research
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
- (2017) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- Application of liquid biopsy in precision medicine: opportunities and challenges
- (2017) Junyun Wang et al. Frontiers of Medicine
- WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death
- (2017) Marcus M. Fischer et al. Science Advances
- Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
- (2017) Euphemia Y. Leung et al. Frontiers in Oncology
- Adipose Tissue-Derived Stromal Cells Primed in Vitro with Paclitaxel Acquire Anti-Tumor Activity
- (2017) A. Bonomi et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
- (2017) Giacomo Canesin et al. PLoS One
- Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
- (2017) Wenzhe Li et al. Scientific Reports
- Synergistic Chemo–Photothermal Therapy of Breast Cancer by Mesenchymal Stem Cell-Encapsulated Yolk–Shell GNR@HPMO-PTX Nanospheres
- (2016) Jiang Wu et al. ACS Applied Materials & Interfaces
- Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
- (2016) Bahriye Aktas et al. BMC CANCER
- Breast cancer stem cell: the roles and therapeutic implications
- (2016) Fang Yang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
- (2016) W. J. Janni et al. CLINICAL CANCER RESEARCH
- CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel
- (2016) Eameema Muntimadugu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial
- (2016) Michail Ignatiadis et al. EUROPEAN JOURNAL OF CANCER
- Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system
- (2016) Arianna Bonomi et al. HEMATOLOGICAL ONCOLOGY
- Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells
- (2016) Han et al. International Journal of Nanomedicine
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Circulating Tumor Cells and Tumor Stem Cells Detection in the Peripheral Blood Mononuclear Cells of Breast Cancer
- (2016) Feng Wang et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Prospects for gene-engineered T cell immunotherapy for solid cancers
- (2016) Christopher A Klebanoff et al. NATURE MEDICINE
- OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells
- (2016) S Bhatt et al. ONCOGENE
- Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA
- (2016) Chuanzhao Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small molecule therapeutics targeting F-box proteins in cancer
- (2016) Yuan Liu et al. SEMINARS IN CANCER BIOLOGY
- Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer
- (2016) Jessica Gasca et al. Oncotarget
- Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
- (2016) Marzia A. Locatelli et al. Oncotarget
- Chemoprevention of oxidative stress-associated oral carcinogenesis by sulforaphane depends on NRF2 and the isothiocyanate moiety
- (2016) Aixian Lan et al. Oncotarget
- Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence
- (2016) Elizabeth A. Mittendorf et al. Oncotarget
- Mammaglobin-A is a target for breast cancer vaccination
- (2016) Samuel W. Kim et al. OncoImmunology
- Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin
- (2015) Masaya Kai et al. BREAST CANCER RESEARCH AND TREATMENT
- Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
- (2015) S. Lanzardo et al. CANCER RESEARCH
- Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
- (2015) G.-B. Jang et al. CANCER RESEARCH
- Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients
- (2015) K. Kalinsky et al. Clinical & Translational Oncology
- Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions
- (2015) M. Damelin et al. CLINICAL CANCER RESEARCH
- Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives
- (2015) Rena Chiotaki et al. CURRENT CANCER DRUG TARGETS
- Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft
- (2015) Silvia Tyciakova et al. JOURNAL OF GENE MEDICINE
- Impact of a New Fusion Receptor on PD-1–Mediated Immunosuppression in Adoptive T Cell Therapy
- (2015) Sebastian Kobold et al. JNCI-Journal of the National Cancer Institute
- Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy
- (2015) Shany Koren et al. MOLECULAR CELL
- An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation
- (2015) Linda Smit et al. Oncotarget
- Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells
- (2015) So-Yeon Park et al. Oncotarget
- Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling
- (2015) Laura Brandolini et al. Oncotarget
- Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway
- (2015) Dan Han et al. Oncotarget
- Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization
- (2015) Yaiza del Pozo Martin et al. Cell Reports
- Impact of a New Fusion Receptor on PD-1–Mediated Immunosuppression in Adoptive T Cell Therapy
- (2015) Sebastian Kobold et al. JNCI-Journal of the National Cancer Institute
- Hedgehog Signaling in the Maintenance of Cancer Stem Cells
- (2015) Catherine Cochrane et al. Cancers
- Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
- (2014) Maria A Papadaki et al. BMC CANCER
- Abstract OT2-6-03: A single arm, preoperative, pilot study to evaluate the safety and biological effects of orally administered reparixin in early breast cancer patients who are candidates for surgery
- (2014) LJ Goldstein et al. CANCER RESEARCH
- Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
- (2014) A. Makkouk et al. CANCER RESEARCH
- Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer
- (2014) V. Tiriveedhi et al. CLINICAL CANCER RESEARCH
- Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer
- (2014) Costanza Paoletti et al. CLINICAL CANCER RESEARCH
- Genomic High-Resolution Profiling of Single CKpos/CD45neg Flow-Sorting Purified Circulating Tumor Cells from Patients with Metastatic Breast Cancer
- (2014) R. P. L. Neves et al. CLINICAL CHEMISTRY
- First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors
- (2014) Beate Schultheis et al. JOURNAL OF CLINICAL ONCOLOGY
- Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug delivery
- (2014) Luisa Pascucci et al. JOURNAL OF CONTROLLED RELEASE
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- (2014) François-Clément Bidard et al. LANCET ONCOLOGY
- ALDH1 is a better clinical indicator for relapse of invasive ductal breast cancer than the CD44+/CD24− phenotype
- (2014) Ying Zhong et al. MEDICAL ONCOLOGY
- Taxane-induced hedgehog signaling is linked to expansion of breast cancer stem-like populations after chemotherapy
- (2014) Jennifer Sims-Mourtada et al. MOLECULAR CARCINOGENESIS
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential
- (2014) Aleksandra Markiewicz et al. PLoS One
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Eph receptor and ephrin function in breast, gut, and skin epithelia
- (2014) Bethany E Perez White et al. Cell Adhesion & Migration
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Defining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model
- (2013) Ivelina Gueorguieva et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice
- (2013) Augusto Pessina et al. BRITISH JOURNAL OF HAEMATOLOGY
- Role of microRNAs in breast cancer
- (2013) Ramesh Singh et al. CANCER BIOLOGY & THERAPY
- Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses
- (2013) Y Xie et al. CANCER GENE THERAPY
- HER2 and Breast Cancer Stem Cells: More than Meets the Eye
- (2013) H. Korkaya et al. CANCER RESEARCH
- ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program
- (2013) E. Charafe-Jauffret et al. CANCER RESEARCH
- Targeting ROR1 Inhibits Epithelial-Mesenchymal Transition and Metastasis
- (2013) B. Cui et al. CANCER RESEARCH
- The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
- (2013) M. A. Salvador et al. CLINICAL CANCER RESEARCH
- Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
- (2013) A. F. Schott et al. CLINICAL CANCER RESEARCH
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetically engineered T cells for the treatment of cancer
- (2013) M. Essand et al. JOURNAL OF INTERNAL MEDICINE
- Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer
- (2013) Lisha Xiang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms
- (2013) Dhruv Kumar et al. Molecular Cancer
- First microRNA mimic enters clinic
- (2013) Aaron Bouchie NATURE BIOTECHNOLOGY
- Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
- (2013) Irène Baccelli et al. NATURE BIOTECHNOLOGY
- The search for ESR1 mutations in breast cancer
- (2013) Steffi Oesterreich et al. NATURE GENETICS
- Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
- (2013) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
- (2013) L. Zhang et al. Science Translational Medicine
- Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
- (2013) Poornima Bhat-Nakshatri et al. Scientific Reports
- Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis
- (2012) Guislaine Barrière et al. BMC CANCER
- Secreted CLU is associated with the initiation of triple-negative breast cancer
- (2012) Danfang Zhang et al. CANCER BIOLOGY & THERAPY
- Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity
- (2012) N. Ning et al. CANCER RESEARCH
- Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
- (2012) B. Ramaswamy et al. CANCER RESEARCH
- Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
- (2012) J. K. Singh et al. CLINICAL CANCER RESEARCH
- Effects of the combination of RAD001 and docetaxel on breast cancer stem cells
- (2012) Xiaobei Zhang et al. EUROPEAN JOURNAL OF CANCER
- A phase II study of RO4929097 in metastatic colorectal cancer
- (2012) Jonathan R. Strosberg et al. EUROPEAN JOURNAL OF CANCER
- The Chemokine Superfamily Revisited
- (2012) Albert Zlotnik et al. IMMUNITY
- Tumor-derived secretory clusterin induces epithelial–mesenchymal transition and facilitates hepatocellular carcinoma metastasis
- (2012) Cun Wang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Silencing IDO in dendritic cells: A novel approach to enhance cancer immunotherapy in a murine breast cancer model
- (2012) Xiufen Zheng et al. INTERNATIONAL JOURNAL OF CANCER
- Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells
- (2012) Prajakta S. Oak et al. INTERNATIONAL JOURNAL OF CANCER
- Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis
- (2012) Venkata Lokesh Battula et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
- (2012) Hyukjin Lee et al. Nature Nanotechnology
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells
- (2012) Magdalena Ksiazkiewicz et al. PATHOBIOLOGY
- Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer
- (2012) Robin M. Hallett et al. PLoS One
- Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN
- (2012) Mingli Han et al. PLoS One
- Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
- (2012) S. J. Conley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells
- (2012) Toshiro Shimo et al. Breast Cancer
- The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles
- (2011) Yang Zhang et al. BIOMATERIALS
- Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
- (2011) Alysha K. Croker et al. BREAST CANCER RESEARCH AND TREATMENT
- Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology
- (2011) George Somlo et al. BREAST CANCER RESEARCH AND TREATMENT
- TGF /TNF -Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype
- (2011) M. K. Asiedu et al. CANCER RESEARCH
- Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
- (2011) Christina Scheel et al. CELL
- Autophagy positively regulates the CD44+CD24-/lowbreast cancer stem-like phenotype
- (2011) Sílvia Cufí et al. CELL CYCLE
- Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+CD24lo cancer stem cell phenotype
- (2011) James M. Reuben et al. EUROPEAN JOURNAL OF CANCER
- Hyaluronan-CD44 interactions as potential targets for cancer therapy
- (2011) Suniti Misra et al. FEBS Journal
- siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions
- (2011) K Iwamura et al. GENE THERAPY
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy
- (2011) Phuc V Pham et al. Journal of Translational Medicine
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer
- (2011) M Kondratyev et al. ONCOGENE
- The Phenotypic Radiation Resistance of CD44+/CD24−or low Breast Cancer Cells Is Mediated through the Enhanced Activation of ATM Signaling
- (2011) Hong Yin et al. PLoS One
- Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
- (2011) Mark J. Anderton et al. TOXICOLOGIC PATHOLOGY
- In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis
- (2010) Veronique Neumeister et al. AMERICAN JOURNAL OF PATHOLOGY
- Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization
- (2010) A. Gradilone et al. ANNALS OF ONCOLOGY
- Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase
- (2010) Puspa R. Pandey et al. BREAST CANCER RESEARCH AND TREATMENT
- Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells
- (2010) Y. Li et al. CLINICAL CANCER RESEARCH
- Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells?
- (2010) F. Takahashi-Yanaga et al. CLINICAL CANCER RESEARCH
- A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer
- (2010) Margarette Bryan et al. INVESTIGATIONAL NEW DRUGS
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
- (2010) Li Ma et al. NATURE BIOTECHNOLOGY
- Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer
- (2010) Chang Gong et al. PLoS One
- Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models
- (2010) H. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer stem cells in breast cancer and metastasis
- (2009) Jessica C. Lawson et al. BREAST CANCER RESEARCH AND TREATMENT
- Antimitotic chemotherapeutics promote adhesive responses in detached and circulating tumor cells
- (2009) Eric M. Balzer et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting breast stem cells with the cancer preventive compounds curcumin and piperine
- (2009) Madhuri Kakarala et al. BREAST CANCER RESEARCH AND TREATMENT
- Inhibition of γ-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells
- (2009) S Rasul et al. BRITISH JOURNAL OF CANCER
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export
- (2009) Ryohei Katayama et al. CANCER SCIENCE
- Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer
- (2009) S. Chia et al. CLINICAL CANCER RESEARCH
- EMT: When epithelial cells decide to become mesenchymal-like cells
- (2009) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
- (2009) Mark E. Davis MOLECULAR PHARMACEUTICS
- Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies
- (2009) A E G Lenferink et al. ONCOGENE
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance
- (2008) W. Matsui et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started